摘要
目的:探讨低分子肝素钙联合拜阿司匹林治疗急性脑梗死的疗效。方法:将100例急性脑梗死患者随机分为对照组(50倒)和疗组(50例)。对照组给予拜阿司匹林(100mg,1次/d),治疗组给予低分子肝素钙(0.6ml,皮下注射,1次/12b)联合拜阿司匹林(100mg,1/d)。治疗10天为一疗程。将两组治疗前后神经功能缺损程度评分及临床疗效进行比较判定。结果:治疗组总有效率98.0‰对照组总效率80.0%。两组相比有显著性差异(P<0.05,神经功能缺损程度评分均较治疗前降低,而治疗组较对照组减少更明显(P<0.05,血液学标治疗组治疗后与治疗前,与对照组治疗后比较,均无显著性差异(P<0.05。结论:低分子肝素钙联合拜阿司匹林治疗急性脑梗死疗效切而且安全。
Objective：To explore the low-molecular-weight heparin calcium United al aspirin treatment of acute cerebral infarction. Method： 100 patients with acute cerebral infarction were randomly divided into control group （50 Cases） and treatment group （50 cases）. Al control group given aspirin （100mg, 1 times / d）, the treatment group given low-molecular-weight heparin （0.6ml, subcutaneous injection, 1 / 12h） United Bayaspirin （100mg, 1 times / d ）. One treatment course of 10 days. The two groups before and after treatment the degree of neurological deficit score and compared to determine clinical efficacy.ResultsThe total effective rate in treatment group 98.0%, control groUp 80.0% total efficiency. Compared the two groups were significantly different （P 〈0.05）, the degree of nenrological deficit score lower than before treatment, while the treatment group than the more obvious reduction in the control group （P 〈0.05）, hematology target treatment group before treatment, after treatment with the control group after treatment compared with no significant differenee （P 〈0.05）. Conclustion：Low- molecular-weight heparin combined with aspirin worship the exact treatment of acute cerebral infarction and safe.
出处
《中国医药导刊》
2009年第9期1490-1492,共3页
Chinese Journal of Medicinal Guide
关键词
低分子肝素钙
拜阿司匹林
急性脑梗死
Low-molecular-weight heparin calcium
Bayaspirin
Aucte cerebral infarction
